Back to results
US 12,215,142 B2Granted
Antibody fragment degrading and removing abnormal TDP-43
AssigneeNational University Corporation Shiga University of Medical Science
InventorsMakoto Urushitani, Yoshitaka Tamaki
Life of this patent
Estimating the term…
Abstract
A modified antibody fragment comprising an antibody fragment capable of binding to misfolded TDP-43, and a chaperone-mediated autophagy localizing signal peptide.
Claims6
A modified antibody fragment that binds to misfolded TAR DNA-binding protein of 43 kDa, wherein the modified antibody fragment comprises an antibody fragment and a chaperone-mediated autophagy localizing signal peptide comprising KFREQ (SEQ ID NO:
- 8) and linked to the C-terminus of the antibody fragment;
- the antibody fragment comprising:
- a heavy-chain variable region comprising a heavy-chain CDR 1 consisting of an amino acid sequence GFNIKDYY (SEQ ID NO:
- 1), a heavy-chain CDR 2 consisting of an amino acid sequence IDPEDGET (SEQ ID NO:
- 2), and a heavy-chain CDR 3 consisting of an amino acid sequence TIIYYYGSRYVDY (SEQ ID NO:
- 3);
- and
- a light-chain variable region comprising a light-chain CDR 1 consisting of an amino acid sequence SSISSSY (SEQ ID NO:
- 4), a light-chain CDR 2 consisting of an amino acid sequence RTS, and a light-chain CDR 3 consisting of an amino acid sequence QQGSSIPLT (SEQ ID NO:
- 5);
- and
- wherein the antibody fragment is a scFv;
- and
- wherein the antibody fragment and the chaperone-mediated autophagy localizing signal peptide are directly bonded, or an amino acid sequence exists between them.
11 more elements
Dependencies are inferred from the claim text.